KEDM Lite Vol. 3Medtronic – MDT
Pitch Summary: Medtronic is on track to spin off its Diabetes unit, MiniMed, by Q4 2023. This unit represents approximately 10% of Medtronic’s total revenues and is a key growth driver for the company. The spin-off is expected to unlock value for shareholders by allowing Medtronic to focus on its core operations while providing MiniMed […]
KEDM Lite Vol. 3Ramsay Health Care – RHC.AX
Pitch Summary: Ramsay Health Care is planning to spin off its struggling European arm, Santé, by Q4 2026. This strategic move is expected to simplify Ramsay’s operations by removing the lowest-margin and most complex part of the group, which previously hindered a takeover bid by KKR in 2022. The spin-off is anticipated to enhance the […]
KEDM Lite Vol. 4Aspen Aerogels – ASPN
Pitch Summary: Aspen Aerogels has launched a strategic review to reassess its growth strategy amid a challenging market environment. The company is known for its thermal insulation products for electric vehicles, but faced a tough 2025 with a 40% revenue decline due to changes in regulations and incentives. Despite these challenges, Aspen maintains a net […]
KEDM Lite Vol. 4Atrium Therapeutics – RNA
Pitch Summary: Atrium Therapeutics recently completed its spin-off following the acquisition of Avidity by Novartis. The company is focused on developing precision cardiology treatments, with two lead programs targeting rare genetic heart diseases. Atrium has a strong balance sheet with $270m in cash to fund its development pipeline. However, both assets are still pre-IND, making […]
KEDM Lite Vol. 4Talenom Oyj – TNOM.HE
Pitch Summary: Talenom is spinning off its Easor software business in H1 2026. The separation aims to unlock value by allowing Easor to be valued at different multiples compared to Talenom’s accounting services. However, Talenom faces significant challenges, including a 13% drop in Q3 revenue due to customer churn and integration issues from recent acquisitions. […]
KEDM Lite Vol. 4Hexagon AB – HEXAB.ST
Pitch Summary: Hexagon is planning to spin off its Octave unit in Q2 2026. Octave is positioning itself as an AI intelligence company, generating approximately 25% operating margins on very recurring revenues. The spin-off is expected to unlock value by allowing Octave to focus on its core competencies and growth opportunities in the AI sector. […]
KEDM Lite Vol. 5DSM-Firmenich AG – DSFIR
Pitch Summary: DSM-Firmenich AG has completed the sale of its ANH unit for €2.2 billion plus a €0.5 billion earn-out, aligning with market expectations. This divestment significantly alters the company’s financial profile, enabling a shift towards higher growth and margins. Despite cyclical headwinds and a recent drop in share price, the company’s strategic focus on […]
KEDM Lite Vol. 5Roots Corp. – ROOT
Pitch Summary: Roots Corp. has announced a strategic review, potentially leading to a full sale of the company. Despite past struggles, including a bankruptcy of its US unit, Roots has shown modest sales growth and maintains decent EBITDA margins and free cash flow generation. However, the company’s debt remains a concern, although it is manageable. […]
KEDM Lite Vol. 5MiniMed Group, Inc. – MMED
Pitch Summary: MiniMed Group, Inc. has recently started trading independently after spinning off from Medtronic. The company represents about 10% of Medtronic’s total revenues and is considered a key growth driver. Despite a 6% decline in share price post-spin-off, the company’s potential for growth and its strategic importance within the healthcare sector make it an […]
Guest Post: DOVER CORPORATION (NYSE: DOV)Dover Corporation – DOV
Pitch Summary: Dover Corporation, a 169-year-old industrial conglomerate, is positioned as a key player in next-generation military electronic warfare through its Microwave Products Group (MPG). MPG supplies critical RF components for advanced electronic warfare systems like the Angry Kitten pod, which is set for its first combat deployment. The company’s defense business is experiencing significant […]
APi Group: How the story has evolved and what’s nextAPi Group Corporation – APG
Pitch Summary: APi Group has successfully executed its inspection-first strategy, achieving its 13/60/80 framework targets with 13.2% EBITDA margins and 80% free cash flow conversion in FY 2025. The company reported $7.9 billion in revenue, with strong organic growth and a focus on consolidating the fire safety segment. Management’s new 10/16/60+ framework aims for $10 […]
#10: DanahurtDanaher Corporation – DHR
Pitch Summary: Danaher Corporation faces significant challenges in the bioprocessing sector, with its product portfolio exposed to headwinds from shifts in the industry. The company’s recent guidance has disappointed investors, with organic growth projections falling short of expectations. Despite strong order growth, the sustainability of these gains is questionable due to easy comparable periods and […]
#10: DanahurtRepligen Corporation – RGEN
Pitch Summary: Repligen is positioned to benefit from numerous company-specific tailwinds in 2025, making it a compelling investment in the bioprocessing space. The company is expected to capitalize on its strong product lineup and market position, which are supported by favorable industry dynamics. Despite broader market uncertainties, Repligen’s unique strengths and growth drivers set it […]
PUMAPuma SE – PUM.DE
Pitch Summary: Anta Sports has acquired a 29.06% stake in Puma at €35 per share, a significant premium over the current market price of €23. This strategic partnership aims to leverage Anta’s expertise in revitalizing brands, similar to its successful turnaround of Fila in China. Puma’s current financials are underwhelming, with shrinking EBITDA and revenue, […]
An Arbitration Play with a Copper Upside of 20X the stock priceGreenX Metals – GRXMF
Pitch Summary: GreenX Metals offers a compelling investment opportunity by combining a significant arbitration award with a promising copper-silver mining project in Germany. The company has won two UNCITRAL arbitrations against Poland, securing £252 million plus interest for expropriation of Polish coal assets. With enforcement proceedings ongoing, GreenX plans to return 70-80% of arbitration proceeds […]
Presidio Warrant Arbitrage Presidio Production Company – FTW
Pitch Summary: Presidio Production Company, trading under the ticker FTW, presents a compelling investment opportunity following its de-SPAC merger with EQV Ventures. The company offers a high dividend yield of 12-13% and is positioned to benefit from the current oil market supply shock due to the U.S.–Iran conflict. With a low public float of under […]
Stock Trade Compilation Episode Seis: Strata Critical Medical – SRTA
Pitch Summary: Strata Critical Medical, formerly Blade Air Mobility’s Passenger division, has rebranded as a transplant logistics and clinical services platform. The company offers an integrated solution for organ transport, covering air and ground logistics, surgical organ recovery, and perfusion. With a network of regional hubs, surgeons, and perfusionists, Strata has performed over 2,000 NRP […]
Stock Trade Compilation Episode Seis: Kaspi.kz – KSPI
Pitch Summary: Kaspi.kz has transitioned from a growth-focused strategy to a cash-return story, with the board recommending a quarterly dividend following strong financial results. The company reported a 19% increase in revenue and a 10% rise in net income, supporting the sustainability of its dividend payouts. The prior pause in dividends was due to capital […]
Stock Trade Compilation Episode Seis: Sagimet Biosciences – SGMT
Pitch Summary: Sagimet Biosciences is developing denifanstat, a FASN-inhibitor drug targeting both MASH and acne, providing two potential market opportunities. The company’s China partner, Ascletis, has completed a successful Phase 3 trial for acne, meeting all primary and secondary endpoints. With approximately US$120 million in cash, Sagimet has a funded runway for at least another […]
Stock Trade Compilation Episode Seis: Anteris Technologies Global – AVR.AX
Pitch Summary: Anteris Technologies is advancing its DurAVR biomimetic heart valve, which aims to restore physiologic blood flow more effectively than conventional devices. The company has received a US$90 million strategic investment from Medtronic, a major player in the medical device industry, signaling strong validation of its technology. While the company is pre-revenue, the investment […]
